Avotaciclib trihydrochloride
Avotaciclib trihydrochloride (BEY1107) is a potent, orally bioavailable CDK1 inhibitor. It is a valuable research tool for studying locally advanced and metastatic pancreatic cancer, with applications in both in vitro cell-based assays and in vivo preclinical models.
Product Specifications
CAS Number
1983984-01-5
Product Name Alternative
BEY1107, BEY-1107, BEY1107 trihydrochloride, BEY1107 Trihydrochloride, BEY-1107 Trihydrochloride, BEY 1107 Trihydrochloride, BEY 1107, Avotaciclib, Avotaciclib trihydrochloride, Avotaciclib Trihydrochloride
Field of Research
Cell Biology
Purity
98.90% (May vary between batches)
Smiles
Cl.Cl.Cl.Nc1nccc (n1) -c1ccc (O) c (n1) -c1ccnc (N) n1
Molecular Formula
C13H14Cl3N7O
Molecular Weight
390.65
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC223069L3V 200 µL
RNF90 (TRIM7) (NM_203296) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
MBS2070211-01 0.1 mL
FITC-Linked Polyclonal Antibody to Urocortin 3 (UCN3)
Sign In for Pricing
View Details MBS2070211-02 0.2 mL
FITC-Linked Polyclonal Antibody to Urocortin 3 (UCN3)
Sign In for Pricing
View Details